Favipiravir Current Affairs, GK & News
26th Meeting of Group of Ministers on COVID-19
On May 17, 20121, the Union Minister of Health and Family Welfare chaired the 26th meeting of Group of Ministers on COVID-19. Key Outcomes of the meet CoWIN portal is to be made available in Hindi. Also, it will be made available in fourteen regional languages. Around seventeen more laboratories will be added to the ..
Month: Current Affairs - May, 2021
Category: Economy & Banking Current Affairs
Topics: Co-WIN • COVID-19 • Favipiravir • Group of Ministers • INSACOG • mucormycosis • Rapid Antigen Test • Remdesivir • Tocilizumab • Variant of Concern
What is Emergency Use Authorization?
Recently, several drug makers are seeking Emergency Use Authorisation (EUA) for the COVID-19 vaccine. Pfizer had applied for the EUA in UK and has been approved by the Medicines and Healthcare Products Regulatory Agency of the country. Also, the Serum Institute of India and Moderna have also applied for the Emergency Use Authorisation of COVID-19 ..
Month: Current Affairs - December, 2020
Category: International Current Affairs • Legal & Constitution Current Affairs
Topics: COVID-19 vaccine • Emergency Use Authorisation • Favipiravir • Food and Drug Administration • Itolizumab • Pfizer • Remdesivir • U.S. Food and Drug Administration
Lupin Ltd launched its version of Favipiravir under brand name Covihalt, in India
The Indian Pharmaceuticals major company, Lupin, has launched its version of the antiviral drug Favipiravir to treat the deadly COVI 19 disease. It has been informed by the company in an exchange filing. The drug has been launched with the brand name ‘Covihalt’ for the treatment of mild-to-moderate COVID 19 among the patients. The Drug ..
Month: Current Affairs - August, 2020
Category: India Nation & States Current Affairs
Topics: COVID-19 • Covihalt • Favipiravir • Influenza • Lupin • Sun Pharma
India’s First Oral Vaccine for Moderate COVID-19 Cases gets Approval
For the treatment of mild to moderate COVID-19 positive patients across the country, on 19th June 2020, for manufacturing and marketing of oral antiviral drug ‘Favipiravir (Fabiflu)’ was approved by the National Regulatory Authority for Indian pharmaceuticals -Central Drugs Standard Control Organisation (CDSCO) to Mumbai based Glenmark Pharmaceuticals. The approval for the drug was given ..
Month: Current Affairs - June, 2020
Category: Science & Technology Current Affairs
Topics: Central Drugs Standard Control Organisation (CDSCO) • COVID-19 • Favipiravir • Glenmark Pharmaceuticals • Japan • Mumbai • Ribonucleic Acid (RNA) • Russia • Tokyo